These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. Singh S; ; Tiwary NK Indian J Dermatol Venereol Leprol; 2016; 82(5):505-9. PubMed ID: 27212277 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin does not cure pityriasis rosea. Amer A; Fischer H Pediatrics; 2006 May; 117(5):1702-5. PubMed ID: 16651327 [TBL] [Abstract][Full Text] [Related]
8. Oral erythromycin is ineffective in the treatment of pityriasis rosea. Rasi A; Tajziehchi L; Savabi-Nasab S J Drugs Dermatol; 2008 Jan; 7(1):35-8. PubMed ID: 18246696 [TBL] [Abstract][Full Text] [Related]
10. Use of high-dose acyclovir in pityriasis rosea. Drago F; Vecchio F; Rebora A J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760 [TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. Sonthalia S; Kumar A; Zawar V; Priya A; Yadav P; Srivastava S; Gupta A J Dermatolog Treat; 2018 Sep; 29(6):617-622. PubMed ID: 29363373 [TBL] [Abstract][Full Text] [Related]
12. Author's Response--The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. Pandhi D; Verma P; Singal A; Sharma R Indian J Dermatol Venereol Leprol; 2015; 81(1):57. PubMed ID: 25566901 [No Abstract] [Full Text] [Related]
13. Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of Pityriasis rosea. Amatya A; Rajouria EA; Karn DK Kathmandu Univ Med J (KUMJ); 2012; 10(37):57-61. PubMed ID: 22971864 [TBL] [Abstract][Full Text] [Related]
14. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea. Alzahrani NA; AlJasser MI Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009 [TBL] [Abstract][Full Text] [Related]
16. Vesicular pityriasis rosea: response to erythromycin treatment. Miranda SB; Lupi O; Lucas E J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):622-5. PubMed ID: 15324412 [TBL] [Abstract][Full Text] [Related]
17. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. Berg HF; Tjhie JH; Scheffer GJ; Peeters MF; van Keulen PH; Kluytmans JA; Stobberingh EE Antimicrob Agents Chemother; 2004 Nov; 48(11):4183-8. PubMed ID: 15504839 [TBL] [Abstract][Full Text] [Related]
18. The natural history of pityriasis rosea in black American children: how correct is the "classic" description? Amer A; Fischer H; Li X Arch Pediatr Adolesc Med; 2007 May; 161(5):503-6. PubMed ID: 17485628 [TBL] [Abstract][Full Text] [Related]
19. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. Rassai S; Feily A; Sina N; Abtahian S J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):24-6. PubMed ID: 20477925 [TBL] [Abstract][Full Text] [Related]